Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06312722 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Study acronym: PEAK
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 5 to 7v4
  2. Site contacts updated at 5 of 5 sitesv3
  3. Primary endpoints: 1 to 2
    • Study sites: 1 to 5
    • Secondary endpoint revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Urotronic Inc.
6 trials monitored
See 1 trial at risk
The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.
Trial Details
NCT Number NCT06312722
Lead Sponsor Urotronic Inc.
Conditions
(from sponsor)		 Benign Prostatic Hyperplasia
Related terms Prostatic Hyperplasia
Enrollment 92 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov